ISPOR ANNOUNCES 2016-2017 BOARD OF DIRECTORS

Published Jul 5, 2016
Princeton, NJ—July 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the election of the Society’s 2016-2017 Board of Directors that assumed office on July 1, 2016. ISPOR’s Board of Directors are elected by its global membership. Lou Garrison, PhD assumes the role of President for 2016-17 after most recently serving as the Society’s President-Elect. Dr. Garrison is Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington in Seattle, WA, USA. Shelby D. Reed, RPh, PhD was elected to serve as President-Elect for the Society for 2016-17. Dr. Reed is Professor, Duke University in Durham, NC, USA. The following were elected as ISPOR Board Members for 2016-18: - Joanna Lis, MSc, MBA, PhD, Director of Market Access, Sanofi-Aventis (Warsaw, Poland) - Gordon Liu, PhD, PKU Yangtze River Scholar Professor of Economics, Peking University National School of Development, Director, PKU China Center for Health Economic Research (Beijing, China) - Rosanna Tarricone, MSc, PhD, Associate Professor, Bocconi University (Milan, Italy) - John Watkins, MPH, PharmD, Formulary Manager, Premera Blue Cross (Mountlake Terrace, WA, USA) Returning Board members include: Past President: - Daniel C. Malone, RPh, PhD, Professor of Pharmacy, College of Pharmacy and Associate Professor in Mel and Enid Zuckerman College, University of Arizona (Tucson, AZ, USA)  Treasurer: - Zeba M. Khan, RPh, PhD, Vice President, Celgene Corporation (Summit, NJ, USA) CEO and Executive Director: - Nancy S. Berg, CEO and Executive Director, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (Lawrenceville, NJ, USA) Directors: - Nancy Devlin, PhD, Director of Research, Office of Health Economics (London, UK) - Manuel Espinoza, MD, MSc, PhD, Professor, Department of Public Health and Chief, HTA Unit, Catholic University of Chile (Santiago, Chile) and Honorary Visiting Fellow, Centre for Health Economics University of York (York, UK) - Dana Goldman, PhD, Leonard D. Schaeffer Director's Chair and Director, Schaeffer Center for Health Policy and Economics, University of Southern California (Los Angeles, CA, USA)

###

Related Stories

ISPOR Announces Launch of ISPOR Institute for Healthcare Transformation

Nov 10, 2025

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced the launch of its new ISPOR Institute for Healthcare Transformation. The ISPOR Institute is an organic extension of ISPOR that bridges the gap between research and real-world application to further elevate the relevance, use, and impact of HEOR.

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×